Sep 18, 2020

Committed to a Positive and Lasting Impact: The Engelstad Foundation

Samuel Cheshier, MD, PhD, and the Neurologic Cancers Center team at Huntsman Cancer Institute are working to find better treatments for brain cancer, particularly pediatric brain cancer. Many primary brain tumors are incurable from the start, and currently, none are curable once they recur. The need for novel, effective therapies is critical. In 2020, the Engelstad Foundation funded a $100,000 grant at HCI to study a potential immunotherapy treatment for pediatric brain tumors.

Sep 10, 2020

Novel Discovery Challenges a Current Kidney Cancer Paradigm

Newly published research has reversed our understanding of an aspect of kidney tumor growth. Researchers at Huntsman Cancer Institute at the University of Utah discovered that two key proteins have opposite roles than what was previously believed.

Aug 04, 2020

Scientists Develop Models to Prevent Drug Resistance in Lung and Pancreas Cancers

Scientists at Huntsman Cancer Institute at the University of Utah report today the development of new models to study molecular characteristics of tumors of the lung and pancreas that are driven by mutations in a gene named NTRK1. The findings were published today in the journal Cell Reports.

Jul 31, 2020

Research Illuminates Potential New Treatment in Acute Myeloid Leukemia

In a study published in the journal Leukemia, lead author Ami Patel, MD, showed that factors produced by bone marrow support cells allowed leukemia cells to survive treatment with quizartinib, a type of TKI.

Jul 21, 2020

Renewal of Prestigious Designation from the National Cancer Institute

The National Cancer Institute has renewed the designation of Huntsman Cancer Institute (HCI) at the University of Utah as a Comprehensive Cancer Center, the highest federal rank possible for a cancer research organization. This grant awards HCI more than $29 million over seven years, an increase of 84% in annual funding from the previous award cycle.

Jul 17, 2020

Talks with Docs: Heloisa Soares, GI Oncologist

Heloisa Soares, MD, PhD, is not simply a GI oncologist or neuroendocrine tumor expert. She is also a passionate patient advocate and had the opportunity to meet members of Congress about improved patient care. Learn about her advocacy work, Brazilian upbringing, and more.

May 27, 2020

Utah Researcher Awarded Prestigious Grant to Study New Ways to Detect Brain Tumors

Hunter Underhill, MD, PhD, a Huntsman Cancer Institute brain cancer researcher and assistant professor of pediatrics at the University of Utah, was awarded a special National Cancer Institute grant to advance his research in brain tumor detection. Underhill will pursue new ways to detect glioblastoma, a type of aggressive and deadly brain tumor.

May 26, 2020

Melanoma Research Innovations

At Huntsman Cancer Institute, we're committed to delivering a cancer-free frontier. Our cancer researchers are on the cutting-edge of discovery and innovation, and we're excited by what these advancements mean for melanoma prevention and treatment. Together, we're building the future we want.